Clayton, Dubilier & Rice is buying the distributor of packaging and printing supplies.
The generic drugmaker reported strong second-quarter earnings and revenue.
The maker of animal health products beat analysts' second-quarter profit forecasts.
The biopharmaceutical company received a disappointing regulatory update for a potential depressive disorder drug.
The in-flight internet provider trimmed its revenue forecast for the year.
The meatpacker reported weak fiscal third-quarter financial results.
The pet food maker beat analysts' second-quarter earnings forecasts.
Copyright 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
, source